Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 365

1.

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in HIV-positive Persons: The D:A:D Study.

Shepherd L, Ryom L, Law M, Petoumenos K, Hatleberg CI, d'Arminio Monforte A, Sabin C, Bower M, Bonnet F, Reiss P, de Wit S, Pradier C, Weber R, El-Sadr W, Lundgren J, Mocroft A; D:A:D Study group.

Clin Infect Dis. 2018 Jun 14. doi: 10.1093/cid/ciy508. [Epub ahead of print]

PMID:
29912335
2.

Associations between serum albumin and serious non-AIDS events among people living with HIV.

Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, Monforte AD, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study group.

AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001900. [Epub ahead of print]

PMID:
29847331
3.

In Memoriam, Fred Gordin, MD, 1951-2018.

Cohn DL, El Sadr WM, Abrams DI, Neaton JD, Benator DA, Vernon AA.

Clin Infect Dis. 2018 May 29. doi: 10.1093/cid/ciy338. [Epub ahead of print] No abstract available.

PMID:
29846556
4.

Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis.

Achhra AC, Sabin C, Ryom L, Hatleberg C, d'Aminio Monforte A, Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D study group.

J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001722. [Epub ahead of print]

PMID:
29771788
5.

HIV Population Surveys - Bringing Precision to the Global Response.

Justman JE, Mugurungi O, El-Sadr WM.

N Engl J Med. 2018 May 17;378(20):1859-1861. doi: 10.1056/NEJMp1801934. No abstract available.

6.

Achieving the 4th 90 - Healthy Aging for People Living with HIV.

Harris TG, Rabkin M, El-Sadr WM.

AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001870. [Epub ahead of print] No abstract available.

PMID:
29762172
7.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.

Simonsen L, Higgs E, Taylor RJ, Wentworth D, Cozzi-Lepri A, Pett S, Dwyer DE, Davey R, Lynfield R, Losso M, Morales K, Glesby MJ, Weckx J, Carey D, Lane C, Lundgren J; INSIGHT FLU002 and FLU003 Study Groups .

Clin Infect Dis. 2018 May 8. doi: 10.1093/cid/ciy088. [Epub ahead of print]

PMID:
29746631
8.

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.

Lancet HIV. 2018 Jun;5(6):e291-e300. doi: 10.1016/S2352-3018(18)30043-2. Epub 2018 May 3.

PMID:
29731407
9.

A time-motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland.

Palma AM, Rabkin M, Simelane S, Gachuhi AB, McNairy ML, Nuwagaba-Biribonwoha H, Bongomin P, Okello VN, Bitchong RA, El-Sadr WM.

J Int AIDS Soc. 2018 Mar;21(3):e25099. doi: 10.1002/jia2.25099.

10.

Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions.

Sayed S, Cherniak W, Lawler M, Tan SY, El Sadr W, Wolf N, Silkensen S, Brand N, Looi LM, Pai SA, Wilson ML, Milner D, Flanigan J, Fleming KA.

Lancet. 2018 May 12;391(10133):1939-1952. doi: 10.1016/S0140-6736(18)30459-8. Epub 2018 Mar 15. Review.

PMID:
29550027
11.

A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders.

Ehrenkranz PD, Calleja JM, El-Sadr W, Fakoya AO, Ford N, Grimsrud A, Harris KL, Jed SL, Low-Beer D, Patel SV, Rabkin M, Reidy WJ, Reinisch A, Siberry GK, Tally LA, Zulu I, Zaidi I.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25080.

12.

Multiple strategies to identify HIV-positive black men who have sex with men and transgender women in New York City: a cross-sectional analysis of recruitment results.

Franks J, Mannheimer SB, Hirsch-Moverman Y, Hayes-Larson E, Colson PW, Ortega H, El-Sadr WM.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25091.

13.

The Global HIV Epidemic: What Will It Take to Get to the Finish Line?

Katz IT, Ehrenkranz P, El-Sadr W.

JAMA. 2018 Mar 20;319(11):1094-1095. doi: 10.1001/jama.2018.2093. No abstract available.

PMID:
29509836
14.

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25083.

15.

It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study.

Shelus V, Taylor J, Greene E, Stanton J, Pack A, Tolley EE, Branson BM, El-Sadr WM, Pollydore J, Gamble T.

PLoS One. 2018 Feb 2;13(2):e0191638. doi: 10.1371/journal.pone.0191638. eCollection 2018.

16.

Patient-level and program-level monitoring and evaluation of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed.

Reidy WJ, Rabkin M, Syowai M, Schaaf A, El-Sadr WM.

AIDS. 2018 Jan 28;32(3):399-401. doi: 10.1097/QAD.0000000000001723. No abstract available.

17.

Factors Associated with Use of Short-Term Pre-Exposure Prophylaxis for HIV Among Female Partners of Migrant Miners in Mozambique.

Falcao J, Zerbe A, Lahuerta M, Baggaley R, Ahoua L, DiMattei P, Morales F, Ramiro I, El-Sadr WM.

AIDS Patient Care STDS. 2017 Dec;31(12):528-534. doi: 10.1089/apc.2017.0179.

PMID:
29211515
18.

Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study.

Branson BM, Chavez PR, Hanscom B, Greene E, McKinstry L, Buchacz K, Beauchamp G, Gamble T, Zingman BS, Telzak E, Naab T, Fitzpatrick L, El-Sadr WM; HIV Prevention Trials Network (HPTN) 065 Study Team.

Clin Infect Dis. 2018 May 2;66(10):1581-1587. doi: 10.1093/cid/cix1053.

PMID:
29186421
19.

Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing individual health and population impact.

Ellman TM, Alemayehu B, Abrams EJ, Arpadi S, Howard AA, El-Sadr WM.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25007. No abstract available.

20.

The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial.

Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM.

Trials. 2017 Nov 21;18(1):552. doi: 10.1186/s13063-017-2184-0.

Supplemental Content

Loading ...
Support Center